Asimov

Some biotechnology papers that were published this week: 1. Writing in Nature, French biotechnologists this week described an engineered enzyme that can be embedded into a PLA matrix and then fully biodegrade the material “under home-compost conditions [about 28 °C] within 20-24 weeks.” Importantly, this approach is compatible with existing industrial processes to make PLA. The enzymes were engineered such that they don’t break down when exposed to the high heats required to mold plastics, and they don't break down during long-term storage of said plastic. (https://lnkd.in/gFtG5h9n) 2. Benchmarking language models for biology. Future House released a set of 2,457 multiple choice questions to evaluate the capabilities of language models to decipher images in research papers, modify sequences of nucleic acids, and much more. Benchmarks are really important because they give researchers a “lay of the land,” so to speak, enabling them to compare models and then push them to get better on tasks that we care about. Benchmarks are a way to drive progress forward. (https://lnkd.in/erNAwxZc) 3. Cells spinning on wheels. Scientists made tiny buckets called "microtraps" and placed them on the spokes of a wheel. As algae get caught in the cages, they swim forward and spin the wheel around. Check out the paper to watch the videos! (https://lnkd.in/eS-hSQys) Our weekly digest has more details on each of these papers. It also includes dozens of additional links and news stories. Check it out and subscribe: https://lnkd.in/ekeHcB7z

Every week, we round up papers and news in biotechnology and share them in a newsletter. This week's digest features five gene-editing advances, some thoughts on OpenAI's partnership with Los Alamos, and dozens more links. Read it here: https://lnkd.in/eYWFk5Xx

The Biotech Digest is our weekly round-up of biotechnology papers and news from the last week. This week's post features small molecules for sickle cell disease, artificial cells controlled with heat, and a website to analyze single-cell data. Plus dozens more links. Check it out and subscribe here: https://blog.asimov.com/

Biotech Digest No. 3 Every week, we collect and share papers and news about progress in biotechnology. This week: An epigenetic editor to silence prions, a genome-editing tool that can duplicate chromosomes, and yeast paintings. Read more: https://lnkd.in/egtEPJ6w

Science Twitter. Cheaper GLP-1s. Recoding E. coli. On Friday we published our weekly digest on the blog, summarizing three of the most interesting science stories from the last week, as well as an extensive list of papers you might have missed. Read it in full here:

Biotech Digest #2 This week: Progress toward a 57-codon E. coli, cheaper weight-loss drugs are coming, and biology papers show up on Twitter more than other platforms. Read the full edition and subscribe here: https://lnkd.in/ec8PyhUV

New technologies appear all the time. Large-language models, protein design, gene drives, and so on. How can we think through their potential risks? A good starting point, we think, is to answer a single question: “Does this technology overcome protections that currently keep things safe?” Read our new blog on the legacy of Asilomar and frameworks to mitigate biorisks: https://lnkd.in/eZj7kGwU

Self-healing peptide glass. Gene therapy for cystic fibrosis. Inserting large DNA fragments into the genome. Some of last week's biotechnology papers and news which we included in our weekly digest. You'll find a fresh digest every Friday on our blog, so be sure to subscribe. Read the first digest in full here on LinkedIn

We're launching a weekly digest, highlighting papers and news stories in biotechnology. Our goal is to build a useful resource for students and scientists hoping to learn more about the field and track progress. Issues are written by Niko McCarty, our Head of Creative. Check out the first post and subscribe to receive future issues. https://lnkd.in/eQfRnkPi

The aerospace and electronics industries have long applied computational models to not only design airplanes and chips, but also to simulate and optimize their performance. There have, until recently, been few comparable tools for biotechnology. This month in Genetic Engineering & Biotechnology News, we discuss computer-aided design in biology, and how Asimov’s holistic application of genetic, cellular, and bioprocess models enables us to boost antibody and viral vector titers in our bioproduction workflows. You can read the full article here. Also, if you’re going to be at the Cambridge Healthtech Institute's Bioprocessing Summit in Boston in August, Asimov’s Head of Process Modeling Will Johnson will be presenting on the same theme. https://lnkd.in/eqD76V4R